Hinge Health, Inc. · Data processing and cloud

HNGE

Moderate riskNext report: In 6 days (est.)

View price ↗

The short version

A company still losing money with growing sales. Institutions are adding.

Going well

Sales up 53% in the latest quarter vs a year ago
Sales up 51% last year
No debt reported

Watch out for

Losing money, losses are large next to sales

Money moves

Insiders sold $26.0M in the last 30 days, all through pre-planned sales
Institutions added 3.3% to their holdings in the quarter ending June 2026 (193 bought, 91 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$111.61+0.3% that day

Company value: $9.3B; Share price times all shares
Price vs profit (P/E): 37.0x; You pay about $37 for each $1 of yearly profit
Price vs sales: 12.9x; Company value is 12.9 times a year of sales
Cash vs value: 3%; Cash as a share of company value

From HNGE's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 10 quarters, from SEC filings

Sales, Jun '26

$212.8M+53% vs a year earlier

Mar '24Tap a barJun '26

Last 12 months: $720.1M, up 50% from the 12 months before.

What the price assumes

Your guesses, our math

Move the sliders to your own view of HNGE. Starting points are the company's recent numbers.

Sales growth+30% a yearRecently: +50% a yearProfit margin15%Last 12 months: 15.1%P/E at the end37xToday: 37.0x. Many steady companies trade at 12x to 25xShare count change0% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$2.7B

Profit in 5 years$401M

Price these guesses point to$177.86+59% vs $111.61 todayAbout +9.8% a year, before dividends

What today's price needs: with a 15% margin and a 37x P/E, sales would have to grow about 18% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/4Mixed

PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-89.9%
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$170.7M
PassGross margin 40%+Pricing power: sells for well above what it costs to make.79.6%

Revenue: $587.9M; +50.6% vs prior year
Total debt: None; 0.00x equity
Current ratio: 1.47x; short-term assets / bills due
Free cash flow: $170.7M; 29.0% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, profitable every year, share count not growing. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 4

Revenue: $212.8M; +53.0% YoY
EPS: $0.52; vs -$13.10
Op. margin: 19.0%; +436.5 pts
Gross margin: 86.4%; +16.1 pts
Free cash flow: $101.3M
Share count: +89.9%; vs a year ago

Insider rating

Last 90 days

43Mixed

Pre-planned sales of $26.0M (weaker signal)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 4.9
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+3.3%

Institutions added 3.3% to their holdings. 193 bought, 91 sold. 5 quarters of net buying in a row.

Shares held by institutions58.1M

Sep '24Jun '26

Safety check

From SEC filings

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

No debt reported

Shares outstandingLatest reported

83M

Why moderate risk

Losing money, losses are large next to sales

Earnings reports

Last 5

Next reportIn 6 days (est.)Estimated from the same quarter last year

Results filedAug 4
Results filedMay 5
Results filedFeb 10
Results filedNov 4, 2025
Results filedAug 5, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (passive)Aug 14 · View filing ↗Big holder 5%+ holder update (passive)Aug 14 · View filing ↗Big holder 5%+ holder update (passive)Aug 13 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$26.0M3 insiders, 3 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Gabriel M.i. MecklenburgDirector	Sell	200K	$103.13	$20.6M	0	Oct 12Filing ↗
Sold entire stake $101.53 to $104.34 across 4 trades Pre-planned sale (10b5-1) Filed 1 day after
James BudgeChief Financial Officer	Sell	48K	$103.13	$4.9M	297K	Oct 12Filing ↗
-13.9% of their holdings $101.53 to $104.34 across 4 trades Pre-planned sale (10b5-1) Filed 1 day after
Daniel Antonio PerezCEO & Co-Founder	Sell	4K	$100.20	$411K	0	Oct 6Filing ↗
Sold entire stake Pre-planned sale (10b5-1) Also Director and 10% owner Filed 1 day after